🇩🇪 Germany Country × Condition
diabetes mellitus type 2 Clinical Trials in Germany
Active clinical trials for diabetes mellitus type 2 with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT06047262 Phase 2
Recruiting
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
Enrollment
300 pts
Country
🇩🇪 Germany
Marc Donath
View Trial → NCT06890208
Recruiting
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave
Enrollment
240 pts
Country
🇩🇪 Germany
Universitätsklinikum Hamburg-Eppend...
View Trial → NCT01477957
Recruiting
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism
Enrollment
450 pts
Country
🇩🇪 Germany
German Diabetes Center
View Trial → NCT07068295 Phase 1
Recruiting
A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump
Enrollment
65 pts
Country
🇩🇪 Germany
Novo Nordisk A/S
View Trial → Frequently Asked Questions
How many diabetes mellitus type 2 clinical trials are active in Germany?
There are currently 4 active clinical trials for diabetes mellitus type 2 with sites in Germany, of which 4 are actively recruiting patients.
How can I join a diabetes mellitus type 2 clinical trial in Germany?
To join a diabetes mellitus type 2 clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are diabetes mellitus type 2 trials in Germany?
Active diabetes mellitus type 2 trials in Germany span Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.